AMAGRI brings together economic and social science researchers who, through a range of projects, are studying the way antibiotics are used in agriculture. They are looking at how the dominant model of intensive farming supported by increasing recourse to antibiotics came into being and are asking to what extent this model is being challenged (or not) by current dynamics that are striving to reduce agriculture’s technical, economic and social dependence on antimicrobials. More broadly, these projects aim to understand how the problem of antimicrobial resistance (AMR) came about and how the system that regulates veterinary medicines is now being put to the test.
AMR refers to the capacity of bacteria to resist the pharmacological action of antibiotics. The overuse and misuse of these drugs in both human medicine and agriculture are among the main causes of this phenomenon, which is a major issue for public health, animal health and environmental protection (One Health). By studying the current recompositions of the system that regulates veterinary medicines, AMAGRI wants to understand how the uses of antibiotics in animal farming are governed. It does so via four main themes: knowledge and practices, professions and organisations, markets and circulations, policies, expertise and controversies. The website allows researchers involved in AMAGRI projects to share their work, along with broader resources and reflections from the social sciences’ AMR community. It concerns all scientists, professionals and private individuals interested or involved in the fight against AMR.
Our projects receive, or have received, funding from numerous organisations
I am a postdoctotoral researcher in sociology at INRA (IRISSO, Paris-Dauphine University). My current researches focus on AMR within ROADMAP projects (INRA/IRISSO).
I work on global health policies, especially on the regulation of human, ecosystem and animal health. My previous researches focus both on the construction of One Health categories, its impacts in terms of governance and professional groups involved (vets, medical professions, ecologists) and the interactions between Global Health and Biodiversity.
Besides, I did a PhD in political science which tackles the evolution of the State inspectors working at slaughterhouses, doing some “dirty work” in the ministry of Agriculture but also the French meat safety public policy. I propose an ethnography of the slaughterhouse, through the work of sanitary controllers. I am interested in the occupational health issues of these inspectors in charge of meat control in slaughterhouses and wonder how the working conditions and MSDs of these agents impact the legitimacy of their mission, modify the representations related to their profession and thoroughly question their professional group.
I am a senior researcher in sociology at INRAE (French Institute for Agricultural and Environmental Research), based at IRISSO, Paris-Dauphine University, and currently Honorary Assistant Professor at the London School of Hygiene & Tropical Medicine, collaborating with the AMIS team and the AMR Centre.
I work on animal health policy and the veterinary profession, especially on the regulation of veterinary medicines. My research focuses on the controversies and governance of the AMR problem, the transformations of farm animal veterinary medicine, the veterinary drug market and the role of farmers and the livestock industry in antimicrobial stewardship. I am the PI of AMAGRI and ROADMAP projects.
I am an historian of science, lecturer at Paris-Saclay University and a member of EST research unit (Science and Technology Studies research unit, EA 1610). My research aims to understand the mechanisms and issues underlying the medicalization of agriculture, by focusing more specifically on the use of drugs in livestock farming and their influence on the way animal health is conceived, between human medicine, veterinary medicine and agricultural sciences.
For several years, I have been interested in the various issues that have led to the introduction of antibiotics in livestock farming and how these drugs have helped to transform veterinary and agricultural practices in France and the United Kingdom. I have also studied how antimicrobial resistances have been handled by various actors – whether experts called by French public authorities or not – and with what consequences regarding the management of the problem until the 1960s.
Sociologist at INRA-ASTER (Mirecourt, France), I have a dual education as an agricultural engineer (AgroParisTech, specialising in animal sciences) and as a doctor in agricultural sociology. My current work focuses on the processes of technical innovation related to the agro-ecological transition of livestock farming. I am particularly interested in alternative methods of animal health management and new breeding methods that are developed by "grazier" breeders' associations.
In the AMAGRI project, I study the transformations of the veterinary profession by focusing on farm animal practices that have a mixed clientele (canine / ruminant breeding). The aim is to describe and analyse the evolution of the activity of these offices, which includes direct animal care, the prescription of medicines and the development of new services such as livestock audits, herd monitoring, or alternative care methods (phyto-aromatherapy).
I am a historian, post-doctoral fellow at the Centre Alexandre-Koyré (EHESS, CNRS, MNHN). My research focuses on the history of medicine and health since the 19th century, combining local, national and international scales. My doctoral research has dealt with the history of influenza in France. At the University of Zürich, as a research and teaching assistant at the chair of the history of medicine, his investigations turned to the history of the relationship between human and animal health, from a perspective of the history of knowledge and public action.
I am now conducting research on the history of international regulations on the problem of antibiotic resistance in animal husbandry, as part of funding from the DIM One Health of the Île-de-France region (2019-2021).
For several years, I have been conducting research on the power relationships at play in health and environmental policies, on the production of scientific knowledge and on the circulation of molecules (industrial chemicals, drugs, pesticides). My work focuses in particular on the role of corporations in regulating the commodities they produce.
In the AMAGRI project, I am investigating both public policies adopted to regulate the prescription of antibiotics in livestock production and the production of an international expertise on antimicrobial resistance. I am particularly interested in the veterinary drug package adopted by the European Union at the beginning of 2019 and the forms of knowledge and expertise used to categorise certain drugs as "critical antibiotics" in various bodies (in particular the European Medicines Agency and the World Health Organisation).
In 2017-2019, I was involved in the MEDICI project, which focused on the trajectory and uses of the notion of "conflict of interest" in the field of medicines. This project's objective was to follow the methods of problematization and management of conflict of interest, the tools used to limit their effects, and the disputes that they support. As part of my thesis and a project funded by IFRIS, I worked on the construction of "regulatory knowledge" mobilized in the expertise on chemicals, through the cases of the US Toxic Substances Control Act of 1976 and the European REACH Regulation of 2006. The latter is at the heart of the book I published with Éditions La Découverte.
I am a sociologist at CIRAD (France, UMR Moisa). My interest lies on sanitary risks and global health, in the context of low- and middle-income countries. My research focuses mainly on risks related to animal husbandry, in relation with emerging infectious diseases, antimicrobial resistance, and in relation with the One Health paradigm.
I am currently working in Mozambique on the veterinary drug market, and the national action plan for facing the threat of antimicrobial resistance.